Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 58083

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"

Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018

Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."

Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018

Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."

Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018

Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."

Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
On Sep 2018

Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."

Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata

Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
On Aug 2018

Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".

Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
On Aug 2018

Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".

Dr. Mamta Gupta
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018

Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.

Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."

Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
On May 11,2011

Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."

Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
On April 2011

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.

Dr. Anuradha
On Jan 2020

Important Notice

Original article / research
Year : 2022 | Month : October | Volume : 16 | Issue : 10 | Page : OC15 - OC17 Full Version

Predictive Significance of High Sensitive C-reactive Protein in Subclinical Hypothyroidism: A Prospective Observational Study

Published: October 1, 2022 | DOI:

1. Associate Professor, Department of General Medicine, Krishna Rajendra Hospital, Mysore Medical College and Research Institute, Mysuru, Karnataka, India. 2. Senior Resident, Department of General Medicine, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.

Correspondence Address :
Dr. HA Krishnamurthy,
Associate Professor, Department of General Medicine, Krishna Rajendra Hospital, Mysore Medical College and Research Institute, Mysuru-570001, Karnataka, India.


Introduction: Subclinical hypothyroidism (SCH) is more common than overt hypothyroidism. It is associated with increased risk of dyslipidaemia, Coronary Artery Disease (CAD), left ventricular diastolic dysfunction, peripheral vascular diseases and chronic inflammation. Chronic inflammation plays a significant role in clinical manifestations and systemic organs injury in hypothyroidism. High-sensitivity C-Reactive Protein (hs-CRP) is a pentameric protein produced by the liver, and its level increases in response to inflammation. There are not much studies to prove that chronic inflammation could be a major risk factor for conversion of subclinical hypothyroidism in to overt hypothyroidism.

Aim: To study the role of chronic inflammation as a risk factor for conversion of SCH in to overt hypothyroidism with lipid abnormalities and cardiac dysfunction, by using inflammatory markers like hs-CRP.

Materials and Methods: This prospective observational study was conducted at KR hospital, Mysuru, Karnataka, India, from August 2019 to September 2020 among 112 subjects of subclinical hypothyroidism attending the Outpatient Department. The data regarding detailed history and clinical examination were collected from all the patients. Investigations such as Thyroid Stimulating Hormone (TSH), Triiodothyronine (T3), Thyroxine (T4) levels hs-CRP level, lipid profile, Electrocardiogram (ECG), Random Blood Sugar (RBS), Renal Function Test (RFT), Complete Blood Count (CBC), 2D-Echocardiography were done on day one and after six months. The data analyses was done by using the Chi-square test or Fisher’s-Exact test. The factors which were significant as per the Chi-square test were selected and subjected to multivariate analysis.

Results: The number of cases of subclinical hypothyroidism (hs- CRP >3 mg/L, mean TSH=9.1±2.1 microIU/mL) at first day were 23 (20.53%). At the end of six months, those converted to overt hypothyroidism (mean TSH=11.4±2.3 microIU/mL) were 14 (12.5%) patients. The patients with hs-CRP of >3 mg/L, with mean TSH of 11.4±2.3 microIU/mL at the end of six months of study, had left ventricular dysfunction in 68 (60.07%) patients. In the same group, the low-density lipoprotein cholesterol >160 mg/dL was found in 60 (53.57%) patients and serum triglycerides level >200 mg/dL was found in 51 (45.53%) patients (p-value <0.05).

Conclusion: Chronic inflammation is one of the major risk factors for conversion of subclinical hypothyroidism in to overt hypothyroidism with associated cardiovascular dysfunction and dyslipidaemia.


Cardiovascular system, Chronic inflammation, Dyslipidaemia

Subclinical Hypothyroidism (SCH) is defined by raised Thyroid Stimulating Hormone (TSH) value and normal levels of thyroid hormones- Triiodothyronine (T3), Thyroxine (T4), associated with few or no symptoms and signs of hypothyroidism (1). It is referred as a state of mild thyroid failure and is essentially a laboratory diagnosis. The prevalence of SCH increases with age and is the most common thyroid abnormality in older subjects (2). SCH is more common than overt hypothyroidism (1).

The prevalence of overt hypothyroidism is 4%, while prevalence of subclinical hypothyroidism has been reported to range from 6-8% for women (10% over the age of 60 years) and 3% for men (1). Euthyroidism is diagnosed, if the TSH is 0.3-4.5 microIU/mL, T3 is 80 to 220 ng/dL, and T4 is 5 to 12 microgm/dL. SCH is diagnosed if TSH is 4.5 to 10 microIU/mL with normal thyroid hormones. Overt hypothyroidism is diagnosed if TSH is >10 microIU/mL (1),(2).

Subclinical hypothyroidism was associated with increased risk of dyslipidaemia, Coronary Artery Disease (CAD), left ventricular diastolic dysfunction and peripheral vascular diseases and chronic inflammation (3). Chronic inflammation plays a significant role in clinical manifestations and systemic organs injury in hypothyroidism. If the chronic inflammation is untreated, it damages the thyroid gland and may lead to hypothyroidism (4). Later it may lead to increased morbidity and mortality due to systemic organ dysfunction (5). The high-sensitivity C-reactive Protein (hs-CRP) is a pentameric protein produced by the liver and its level increases in response to inflammation (6). An early diagnosis and treatment may prevent the onset of overt hypothyroidism and its associated complications (4). Hence, the present study was under taken to evaluate the role of chronic inflammation as a risk factor for conversion of SCH in to overt hypothyroidism with lipid abnormalities and cardiac dysfunction, by using inflammatory markers like hs-CRP.

Material and Methods

This prospective observational study was conducted at KR Hospital, Mysuru, Karnataka, India, from August 2019 to September 2020 among 112 subjects of subclinical hypothyroidism attending the Outpatient Department. The data collection was started after obtaining ethical clearance from Institutional Ethics Committee, Mysore Medical College and Research Institute, (IEC No.ECREG:ECR/134/ Inst/KA/2013).

Inclusion criteria: Subjects with subclinical hypothyroidism with normal thyroid hormone levels with TSH level between 4.5 to 10 microIU/mL (1).

Exclusion criteria: Patients with familial hyperlipidaemia, coagulation disorders, severe systemic disease, overt hypothyroid patients, systemic arterial hypertension, diabetes mellitus, renal failure, underlying known cardiac disorder, pregnancy, connective tissue diseases and malignancy were excluded from the study.

Sample size calculation: The sample size was calculated based on the average prevalence rate of SCH (5%) by using the Cochran’s formula (7):


Where Z is z score (1.962),
p is prevalence of subclinical hypothyroidism,
q was (1-p),
e2 was precision value

The actual sample size by calculation was 76, but it was increased to 112 to have adequate number and to draw significant conclusion.

Study Procedure

Information was collected as per proforma after obtaining the informed consent from the study subjects. The subjects underwent detailed history, clinical examination, investigations such as Thyroid Stimulating Hormone (TSH), Triiodothyronine (T3), Thyroxine (T4) level, hs-CRP, Electrocardiogram (ECG), Random Blood Sugar (RBS), Renal Function Test (RFT), Complete Blood Count (CBC), 2DEchocardiography on day one. The study subjects were followedup for six months and the same investigations were repeated.

• TSH of 0.30 to 4.5 microIU/mL was considered normal.
• hs-CRP levels (4)
0.01 to 1 mg/L was considered as low-risk group,
1 to 3 mg/L intermediate-risk group, and
>3 mg/L as severe-risk group
• LDL cholesterol >160 mg/dL and Triglycerides >200 mg/dL were taken as abnormal values, as per National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) guidelines for metabolic syndrome (8).

The T3, T4, and TSH was measured by using electro chemiluminescent immunoassay, fasting lipid profile was measured by enzymatic calorimetric method, and hs-CRP was measured by infrared particle immunoassay method (9).

Statistical Analysis

The data analyses was done by using the Statistical Package for Social Sciences (SPSS, Inc, Chicago) for windows software, version 18.0. Descriptive statistics such as mean and Standard Deviation (SD) for continuous variables, frequency, and percentage for categorical variables were determined. Chi-square and Fisher’s-Exact tests (wherever appropriate) was used to find association between chronic inflammation with SCH and overt hypothyroidism and its complications. The level of significance was set at 0.05. The factors which were significant by Chi-square test were selected and subjected to multivariate analysis.


In this study 84 (75%) patients were in the age group of <60 years. The majority were female, 68 (60.7%) patients (Table/Fig 1). The number of patients with SCH converted to overt hypothyroidism by the end of six months of study were 12.5% (Table/Fig 2).

At six months, in patients of SCH, with hs-CRP >3 mg/L had significant Left Ventricular (LV) dysfunction with high LDL cholesterol and triglycerides level (p-value <0.05) (Table/Fig 3).


The present study was done to know the association between chronic inflammation and conversion of SCH in to overt hypothyroidism with cardiac dysfunction with lipid abnormalities. There were significant changes found at the end of six months of study, with respect to conversion of SCH to overt hypothyroidism with cardiac dysfunction and lipid abnormalities.

As per the study by Anwer MS et al., the prevalence of conversion of SCH to overt hypothyroidism was 14%, and patients with SCH have 2.8 times more risk of conversion to overt hypothyroidism as compared to healthy volunteers. The female gender and initial level of high serum TSH (4.5 to 10 microIU/mL) were the most important predictors of conversion of SCH in to overt hypothyroidism (10).

As per Amouzegar A et al., the Thyroid Peroxidase Antibodies (TPOAb) positive cases had a high-risk of converting in to overt hypothyroidism after 3 years with a relative risk of 4.14, 95% confidence interval 2.57-6.67 (11). Overt hypothyroidism was associated with reduced myocardial contractility, heart rate, and stroke volume (12). In the present study, 14 (12.5%) patients had hs-CRP level >3 mg/L in subjects, who converted from SCH in to overt hypothyroidism. The chronic inflammation with increased hs- CRP was found with progressive thyroid failure and was considered as a risk factor for the development of coronary artery disease (6),(13). The SCH patients were associated with high level of cardiac risk factors. Early treatment of SCH may prevent further progression to overt hypothyroidism, correct dyslipidaemia and decrease the risk of death from cardiovascular disease (14). Diastolic dysfunction was common in SCH, therefore early diagnosis and treatment may prevent cardiovascular complications (15).

The SCH has been shown to be associated with increased risk of CAD, peripheral vascular disease and dyslipidaemia (4),(16). SCH needs no intervention, if the serum TSH value is <10 microIU/L, and unless it is associated with co-morbidities like cardiac dysfunction, dyslipidaemia, and significant elevation of antiTPO antibodies (14),(16). The present study attempted to find the association between chronic inflammation (hs-CRP), and conversion of SCH in to overt hypothyroidism (17).

In the present study, among patients with hs-CRP level >3 mg/L patients, 68 (60.07%) had LV dysfunction, 60 (53.57%) had LDL cholesterol >160 mg/dL, and 51 (45.53%) had triglycerides >200 mg/dL at the end of six months. As per the study by Tuzcu A et al., the SCH patients were found to have elevated hs-CRP levels, high total cholesterol, high LDL cholesterol, and triglyceride levels (5). An elevated TSH level correlates with dyslipidaemia and adversely affects the cardiovascular function (18).

A cross-sectional study on the lipid abnormalities in SCH demonstrated a significant elevation of total cholesterol, LDL-cholesterol, apolipoprotein B and Lp(a) in SCH compared with euthyroidism (19). The treatment of SCH with thyroxine would have a favourable effect on the lipid profile by decreasing the total cholesterol and LDL-C (20),(21). A study in Naples, Italy, on 26 SCH subjects found a high incidence of LV dysfunction (22). Age more than 60 years and high hs-CRP level are the strong independent predictors of cardiovascular abnormalities in SCH, and also for the conversion to overt hypothyroidism (22),(23).


The outcomes need to be further studied for a longer duration of follow-up.


The present study found that chronic inflammation plays a big role in converting SCH to overt hypothyroidism. It was also associated with significant elevation in lipid levels, cardiovascular abnormalities in undetected and untreated subjects. So, a close follow-up is needed in all patients with SCH to prevent cardiac morbidity and mortality.


Larry JJ, Mandel Susan J, Weetman AP. Hypothyroidism. Harrison’s Principles of Internal Medicine. 21st edition. McGraw Hill Medical, vol.1:2933-36.
Gourmelon R, Donadio-Andréi S, Chikh K, Rabilloud M, Kuczewski E, Gauchez AS, et al. Subclinical hypothyroidism: Is it really subclinical with aging? Aging Dis. 2019;10(3):520-29. [crossref] [PubMed]
Pearce EN. Hypothyroidism and dyslipidemia: Modern concepts and approaches. Curr Cardiol Rep. 2004;6(6):451-56. [crossref] [PubMed]
Kamath DY, Xavier D, Sigamani A, Pais P. High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective. Indian J Med Res 2015;142(3):261-68. Doi: 10.4103/0971-5916.166582. [crossref] [PubMed]
Tuzcu A, Bahceci M, Gokalp D, Tuzun Y, Gunes K. Subclinical hypothyroidism may be associated with elevated high-sensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr J. 2005;52(1):89-94. [crossref] [PubMed]
Christ-Crain M, Meier C, Guglielmetti M, Huber P, Riesen W, Staub JJ, et al. Elevated C-reactive protein and homocysteine values: Cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis. 2003;166(2):379-86. [crossref] [PubMed]
Uakarn C, Kajohnsak C, Sintao N. Sample size estimation using Yamane and Cochran and Krejcie and Morgan and Green formulas and Cohen statistical power analysis by G*Power and comparisons. Apheit International Journal. 2021;10(2).
Superko HR, Williams PT, Dansinger M, Schaefer E. Trends in low-density lipoprotein-cholesterol blood values between 2012 and 2017 suggest sluggish adoption of the recent 2013 treatment guidelines. Clin Cardiol. 2019;42(1):101-10. [crossref] [PubMed]
Aksoy DY, Cinar N, Harmanci A, Karakaya J, Yildiz BO, Usman A, et al. Serum resistin and high sensitive CRP levels in patients with subclinical hypothyroidism before and after L-thyroxine therapy. Med Sci Monit. 2013;19:210-15. [crossref] [PubMed]
Anwer MS, Hashim R, Khan FA, Ijaz A. Frequency of conversion to overt hypothyroidism in patients with and without subclinical hypothyroidism. J Ayub Med Coll Abbottabad. 2012;24(3-4):166-70.
Amouzegar A, Gharibzadeh S, Kazemian E, Mehran L, Tohidi M, Azizi F. The prevalence, incidence and natural course of positive antithyroperoxidase antibodies in a population-based study: Tehran thyroid study. PLoS One. 2017;12(1):e0169283. [crossref] [PubMed]
McDermott MT, Ridgway EC. Subclinical hypothyroidism is mild thyroid failure and should be treated. J Clin Endocrinol Metab. 2001;86(10):4585-90. [crossref] [PubMed]
Panchal M, Gondaliya UB. A study of high sensitive C reactive protein in subclinical hypothyroidism. International Journal of Contemporary Medicine Surgery and Radiology. 2019;4(1):A85-A87. [crossref]
Sharma R, Sharma TK, Kaushik GG, Sharma S, Vardey SK, Sinha M. Subclinical hypothyroidism and its association with cardiovascular risk factors. Clin Lab 2011;57(9-10):719-24.
Mishra TK, Routray SN, Das S, Behera M. Left ventricular dysfunction in patients with subclinical hypothyroidism and its reversibility after hormone therapy. J Assoc Physicians India. 2005;53:943-46.
Gauna A, Messuti H, Papadopulos G, Benchuga G, Viale F, Marlowe RJ, et al. Acute and chronic hypothyroidism are associated with similar left ventricular diastolic dysfunction relative to the euthyroid state: Results of Doppler echocardiographic comparisons. J Endocrinol Invest. 2011;34(9):e281-86.
Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, et al. Thyroid studies collaboration. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365-74. [crossref] [PubMed]
Anwer MS, Hashim R, Khan FA, Ijaz A. Frequency of conversion to overt hypothyroidism in patients with and without subclinical hypothyroidism. J Ayub Med Coll Abbottabad. 2012;24(3-4):166-70.
Efstathiadou Z, Bitsis S, Milionis HJ, Kukuvitis A, Bairaktari ET, Elisaf MS, et al. Lipid profile in subclinical hypothyroidism; Is L-Thyroxine substitution beneficial. Eur J Endocrinol. 2001;145( 6):705-10. [crossref] [PubMed]
Ayala AR, Danese MD, Ladenson PW. When to treat mild hypothyroidism. Endocrinol Metab Clin North Am. 2000;29(2):399-15. [crossref] [PubMed]
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-34. [crossref] [PubMed]
Biondi B, Fazio S, Palmieri EA, Carella C, Panza N, Cittadini A, et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 1999;84(6):2064-67. [crossref] [PubMed]
Oner FA, Yurdakul S, Oner E, Arslantas¸ MK, Usta M, Mecdi E. Evaluation of ventricular functions using tissue Doppler echocardiography in patients with subclinical hypothyroidism. Turk Kardiyol Dern Ars. 2011;39(2):129-36. [crossref] [PubMed]

DOI and Others

DOI: 10.7860/JCDR/2022/58886.16998

Date of Submission: Jul 06, 2022
Date of Peer Review: Aug 20, 2022
Date of Acceptance: Sep 27, 2022
Date of Publishing: Oct 01, 2022

• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

• Plagiarism X-checker: Jul 07, 2022
• Manual Googling: Sep 09, 2022
• iThenticate Software: Sep 26, 2022 (13%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)